8217 — Ju Fu Tang Biotech Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$32.60m
- -HK$16.05m
- HK$37.56m
Annual cashflow statement for Ju Fu Tang Biotech Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.2 | -9.96 | -17.4 | -5.9 | 23.3 |
| Depreciation | |||||
| Non-Cash Items | 12.2 | 5.55 | 12.9 | -1.08 | -30.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -11.8 | 36.5 | 8.14 | -0.371 | 15.3 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -19.5 | 32.2 | 3.72 | -7.27 | 7.81 |
| Other Investing Cash Flow Items | 0.09 | 0.806 | 0 | — | 7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.09 | 0.806 | 0 | — | 7 |
| Financing Cash Flow Items | -42.5 | -32.9 | -7.87 | 5.38 | -7.64 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.1 | -33.1 | -7.87 | 5.38 | -7.64 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.37 | -0.049 | -4.15 | -1.89 | 7.16 |